Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-10-30
2007-10-30
Campbell, Bruce R. (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023100, C435S235100, C435S006120, C435S455000, C435S002000
Reexamination Certificate
active
10368803
ABSTRACT:
This invention provides cellular gene products which have anti-apoptotic activity in HIV-1 infected cells. Other pro-apoptotic genes and methods of use thereof are also disclosed. The compositions of the invention may be used to advantage to develop novel therapeutic agents for the treatment of HIV infection. The compositions of the invention may also be used to advantage to develop novel therapeutic agents for the treatment of disorders associated with inordinate cellular apoptosis.
REFERENCES:
patent: 6228585 (2001-05-01), Dieckgraefe et al.
patent: 6455674 (2002-09-01), Einat et al.
patent: 6555667 (2003-04-01), Einat et al.
patent: WO99/09049 (1999-02-01), None
Verma et al. Nature 1999, vol. 389, pp. 239-242.
Eck et al. Gne-Based Therapy, In: The parmacological basis of therapeutics, Goodman and Gilman, Ed.s, 1996, pp. 77-101.
Orkin et al. Report and Recommmendation of the Panel to Assess the NIH Investiment in Research on Gene Therapy, NIH, 1995.
Change et al. Journal Biomecial Science 2000, vol. 7, pp. 322-333.
Parlato et al. Cell death and Differentiation 2000, vol. 7, pp. 37-47.
Yin et al. AIDS 2004, vol. 18, No. 4, pp. 587-596.
Feit et al. 2003, J. Pat. Trade. Off. Soc., vol. 85, No. 1, pp. 5-21.
Buck et al. BioTechniques 1999, vol. 27, No. 3, pp. 528-536.
Chi-square test published in Answer.com, Jan. 9, 2007, pp. 1-5.
Finzi, D. et al. “Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy”; [EBSCO Host Research Databases] Science, 0036-8075, vol. 278, Issue 5341, 12p. (1997).
Emerman, M. et al. “HIV-1 Regulatory/Accessory Genes: Keys to Unraveling Viral and Host Cell Biology”; [EBSCO Host Research Databases] Science, 0036-8075, vol. 280, Issue 5371, p. 1880, 5p., 4 diagrams (1998).
Wong, J.K. et al. “Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia”; [EBSCO Host Research Databases] Science, 0036-8075, vol. 278, Issue 5341, p. 1297, 5p, 3 charts, 1 diagram (1997).
Corbeil, J. et al. “Temporal Gene Regulation During HIV-1 Infection of Human CD4+ T Cells”; Genome Research, 11: 1198-1204 (2001).
Diatchenko, L. et al. “Suppression subtractive hybridization: A method for generating differentially regulated or tissue-specific cDNA probes and libraries”; Proc. Natl. Acad. Sci. USA, 93: 6025-6030 (1996).
Geiss, G.K. et al. “Large-Scale Monitoring of Host Cell Gene Expression during HIV-1 Infection Using cDNA Microarrays”; Virology, 266: 8-16 (2000).
Ryo, A. et al. “Serial analysis of gene expression in HIV-1 -infected T cell lines”; FEBS Letters, 462: 182-186 (1999).
Simm, M. et al. “Cloning of differentially expressed genes in an HIV-1 resistant T cell clone by rapid subtraction hybridization, RaSH”; Gene, 269: 93-101 (2001).
Folks, T.M. et al. “Biological and Biochemical Characterization of a Cloned LEU-3—Cell Surviving Infection with the Acquired Immune Deficiency Syndrome Retrovirus”; J. Exp. Med., 164: 280-290 (1986).
Selliah, N. et al. “Cutting Edge: JAK3 Activation and Rescue of T Cells from HIV gp120-Induced Unresponsiveness”; The Journal of Immunology, 160: 5697-5701 (1998).
Scheuring, U.J. et al. “Differential expression profiles of apoptosis-affecting genes in HIV-infected cell lines and patient T cells”; AIDS, 13: 167-175 (1999).
Kinoshita, S. et al. “The T Cell Activation Factor NF-ATc Positively Regulates HIV-1 Replication and Gene Expression in T Cells”; Immunity, 6: 235-244 (1997).
Kinoshita, S. et al. “Host Control of HIV-1 Parasitism in T Cells by the Nuclear Factor of Activated T Cells”; Cell, 95: 595-604 (1998).
Cron, R.Q. et al. “NFAT1 Enhances HIV-1 Gene Expression in Primary Human CD4 T Cells”; Clinical Immunology, 94(3): 179-191 (2000).
Nekhai, S. et al. “Cell Cycle-Dependent Stimulation of the HIV-1 Promotor by Tat-Associated CAK Activator”; Virology, 266: 246-256 (2000).
Liu, R. et al. “Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection”; Cell, 86: 367-377 (1996).
Bushman, F. et al. “New developments in the biology and treatment of HIV”; PNAS, 95(19): 11041-11042 (1998).
Gelezlunas, R. et al. “HIV-1 Nef inhibits ASK1-dependent death signalling providing a potential mechanism for protecting the infected host cell”; Nature, 410: 834-838 (2001).
Hoxie, J.A. et al. “Persistent Noncytopathic Infection of Normal Human T Lymphocytes with AIDS-Associated Retrovirus”; Science, New Series, 229(4720): 1400-1402 (1985).
LaCasse, R.A. et al. “Fusion-Competent Vaccines: Broad Neutralization of Primary Isolates of HIV”; [EBSCO Host Research Databases] Science, 0036-8075, vol. 283, Issue 5400, p. 357, 6p, 33 graphs (1999).
Perrin, L. et al. “HIV Treatment Failure: Testing for HIV Resistance in Clinical Practice”; [EBSCO Host Research Databases], Science, vol. 280, Issue 5371, p. 1871, 3p, 4 graphs (1998).
Fauci, A.S. “Host factors and the pathogenesis of HIV-induced disease”; Nature, 384(6609): 529-534 (1996).
McMichael, A.J. et al. “Escape of Human Immunodeficiency Virus from Immune Control”; Annual Review of Immunology, 15(1): 271-296 (1997).
Chun, T. et al. “Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy”; Proc. Natl. Acad. Sci. USA, 94: 13193-13197 (1997).
Pantaleo, G. et al. “Immunopathogenesis of HIV Infection”; Annu. Rev. Microbiol., 50:825-54 (1996).
Rowland-Jones, S. et al. “New Insights into Host Factors in HIV-1 Pathogenesis”; Cell, 104: 473-476 (2001).
Nabel, G.J. “Challenges and opportunities for development of an AIDS vaccine”; Nature, 410: 1002-1007 (2001).
Landau, N.R. “HIV Recent advances in AIDS research: genetics, molecular biology and immunology”; Current Opinion in Immunology, 11:449-450 (1999).
Ameisen, J.C. “Apoptosis subversion: HIV-Nef provides both armor and sword”; Nature Medicine, 7(11): 1181-1182 (2001).
Casella, C.R. et al. “Vpu Increases Susceptibility of Human Immunodeficiency Virus Type 1-Infected Cells to Fas Killing”; Journal of Virology, 73(1): 92-100 (1999).
Shoshani, T. et al. “Identification of a Novel Hypoxia-Inducible Factor 1-Responsive Gene,RTP801, Involved in Apoptosis”; Molecular and Cellular Biology, 22(7): 2283-2293 (2002).
Lewis, J. et al. “Disruption of Hsp90 Function Results in Degradation of the Death Domain Kinase, Receptor-interacting Protein (RIP), and Blockage of Tumor Necrosis Factor-induced Nuclear Factor-κB Activation”; The Journal of Biological Chemistry, 275(14): 10519-10526 (2000).
Pandey, P. et al. “Negative regulation of cytochromec-mediated oligomerization of Apaf-1 and activation of procaspase-9 by heat shock protein 90”; The EMBO Journal, 19(16): 4310-4322 (2000).
Galea-Lauri, J. et al. “Increased Heat Shock Protein 90 (hsp90) Expression Leads to Increased Apoptosis in the Monoblastoid Cell Line U937 Following Induction with TNF-α and Cycloheximide”; The Journal of Immunology, 157: 4109-4118 (1996).
Swaroop, M. et al. “SAG/ROC2/Rbx2/Hrt2, a Component of SCF E3 Ubiquitin Ligase: Genomic Structure, a Splicing Variant, and Two Family Pseudogenes”; DNA and Cell Biology, 20(7): 425-434 (2001).
Duan, H. et al. “SAG, a Novel Zinc RING Finger Protein That Protects Cells from Apoptosis Induced by Redox Agents”; Molecular and Cellular Biology, 19(4): 3145-3155 (1999).
Kim, T.A., et al., “HIV-1 Tat-mediated Apoptosis in Human Brain Microvascular Endothelial Cells”, J. Immunol., vol. 170: p. 2629-2637, (2003).
Elbim, C., et al., “Redox and Activation Status of Monocytes from Human Immunodeficiency Virus-Infected Patients: Relationship with Viral Load”, J. of Virology, vol. 73: p. 4561-456
Finkel Terri H.
Yin Jiyi
Campbell Bruce R.
Dann Dorfman Herrell & Skillman
Li Bao Qun
Netter Robert C.
Rigaut Kathleen D.
LandOfFree
Cellular genes regulated by HIV-1 infection and methods of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cellular genes regulated by HIV-1 infection and methods of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cellular genes regulated by HIV-1 infection and methods of... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3873464